AB308

· Arcus Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AB308, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies [Phase 1]